Lupin Licenses Salix Digestive Drugs For Canada Market
This article was originally published in PharmAsia News
Executive Summary
Lupin has purchased distribution rights to market two Salix Pharmaceuticals gastroenterology drugs in Canada with options for any other Salix drugs with that indication.